These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19924151)

  • 1. Diabetes: diabetes therapy and cancer risk.
    Vigneri R
    Nat Rev Endocrinol; 2009 Dec; 5(12):651-2. PubMed ID: 19924151
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues.
    Simon D
    Diabetologia; 2010 Jan; 53(1):204-5. PubMed ID: 19859691
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin glargine and incidence of cancer--an ongoing debate.
    Hermanns N; Kulzer B
    J Diabetes Sci Technol; 2010 Mar; 4(2):497-8. PubMed ID: 20307414
    [No Abstract]   [Full Text] [Related]  

  • 4. [The impact of anti-diabetic therapy on cancer development].
    Toda G; Ueki K
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():447-53. PubMed ID: 27266133
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
    Butler PC
    Diabetes; 2009 Nov; 58(11):2427-8. PubMed ID: 19875618
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific PPAR gamma agonists may have different effects on cancer incidence.
    Bambury RM; Iyer G; Rosenberg JE
    Ann Oncol; 2013 Mar; 24(3):854. PubMed ID: 23417919
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes and cancer: a consensus report.
    Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
    Diabetes Care; 2010 Jul; 33(7):1674-85. PubMed ID: 20587728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between diabetology and oncology. Cancer alarm initially without practical consequences].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):16, 18. PubMed ID: 19938774
    [No Abstract]   [Full Text] [Related]  

  • 9. The global implications of diabetes and cancer.
    Shi Y; Hu FB
    Lancet; 2014 Jun; 383(9933):1947-8. PubMed ID: 24910221
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Educating patients about the study"].
    Seissler J
    MMW Fortschr Med; 2009 Jul; 151(30-33):23. PubMed ID: 19722455
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes field cautiously upbeat despite possible setback for leading SGLT2 inhibitor.
    Jones D
    Nat Rev Drug Discov; 2011 Aug; 10(9):645-6. PubMed ID: 21878967
    [No Abstract]   [Full Text] [Related]  

  • 12. [How to calm diabetic patients? About the difficulty of counting to 4].
    Einecke D
    MMW Fortschr Med; 2009 Jul; 151(30-33):24. PubMed ID: 19722456
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes and cancer--an AACE/ACE consensus statement.
    Handelsman Y; Leroith D; Bloomgarden ZT; Dagogo-Jack S; Einhorn D; Garber AJ; Grunberger G; Harrell RM; Gagel RF; Lebovitz HE; McGill JB; Hennekens CH
    Endocr Pract; 2013; 19(4):675-93. PubMed ID: 23978590
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure.
    Walker JJ; Johnson JA; Wild SH
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):132-9. PubMed ID: 24622319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and cancer.
    Chowdhury TA
    QJM; 2010 Dec; 103(12):905-15. PubMed ID: 20739356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?
    Johnson JA; Gale EA
    Diabetes; 2010 May; 59(5):1129-31. PubMed ID: 20427699
    [No Abstract]   [Full Text] [Related]  

  • 17. [Depot insulin with tumor risk. Changing now or staying cool? (interview by Sarah Pampel)].
    Spranger J
    MMW Fortschr Med; 2009 Jul; 151(30-33):22. PubMed ID: 19722454
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetes and cancer: an injurious association].
    Gariani K; Tran C; Philippe J
    Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-diabetic therapy and cardiovascular risk].
    Mannucci E
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the therapy of diabetes mellitus with redul].
    Stratmann FW
    Med Welt; 1968 Aug; 33():1799. PubMed ID: 5712287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.